Skip to content
Screener

Vor Biopharma VOR Q4 2025 Annual earnings

Reported March 30, 2026 · Before market open

EPS$82.04Beat by $83.18
EPS estimate-$1.14

Next report

Nov 12, 2026 (in 2 months)
EPS estimate-$0.81

Financials

Q4 2025

Income statement

See full
Operating income-$36.0M-14.8%

Balance sheet

See full
Cash & equivalents$396.5M+384%
Total debt$3.0M-90.6%
Total equity-$164.3M-70.0%
Total assets$464.1M+225%

Cash flow

See full
Operating cash flow-$22.8M+5.2%
CapEx$314.0K+336%
Free cash flow-$23.1M+4.2%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$286.59M+107%
Enterprise value-$106.89M-221%

Returns & leverage

See full
Current ratio18.2×+13.0×

FAQ

When did Vor Biopharma report Q4 2025 earnings?
Vor Biopharma (VOR) reported Q4 2025 earnings on March 30, 2026 before market open.
What were Vor Biopharma's Q4 2025 revenue and EPS?
Vor Biopharma reported eps of $82.04 for Q4 2025.
Did Vor Biopharma beat estimates in Q4 2025?
EPS beat the consensus estimate of $-1.14 by $83.18.
Where can I find Vor Biopharma's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-127609) and the 10-K periodic report (0001193125-26-130451) directly on SEC EDGAR. The filing index links above go to sec.gov.